Reply - 07/03/18
Doi : 10.1016/j.jaci.2017.09.010
Pavel Kolkhir, MD a, Martin K. Church, PhD, DSc b, Karsten Weller, MD b, Martin Metz, MD b, Oliver Schmetzer, MD b, Marcus Maurer, MD b 
a Department of Dermatology and Venereology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia
b Department of Dermatology and Allergy, Charité–Universitätsmedizin Berlin, Berlin, Germany
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: P. Kolkhir received grants from the DAAD Scholarship 2015 (2 months) and EAACI Clinical Fellowship 2014 (3 months) for other works. K. Weller personally received consultancy fees from Novartis; payment from lectures from Dr R. Pfleger, Essex Pharma, Uriach, UCB, and Moxie; and reimbursement for travel from Novartis. M. Metz personally received consulting fees from Novartis for this work. M. Maurer personally received board membership, consultancy fees, and expert testimony from Novartis and Genetech, and his institution received grants from Novartis and Genentech for other works. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2017
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 3
P. 1166-1167 - mars 2018 Retour au numéro
Article précédent
- Autoimmune chronic spontaneous urticaria
- Clive Grattan
- Retraction notice
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?